Navigation Links
Reaction To ADHD Medication May Be Genetic By Nature

New research points out that the difference in genes might be responsible for the way patients suffering from attention deficit hyperactivity disorder (ADHD) differ in reacting to medications. //

The study, done by the researchers from University of Illinois at Chicago, had found that children with a variant form of a dopamine transporter gene -- a variant known to be associated with ADHD -- responded poorly to one of the most common stimulant medications, methylphenidate. The transporter gene encodes a protein on the nerve cell membrane that helps to clear the neurotransmitter dopamine from the nerve junction.

The researchers had first reported an association of this gene with ADHD 10 years ago. In the new study, they had examined the relationship between the gene and patients' medication response over a four-week period, first on a placebo and then on three increasing dosages of methylphenidate.

The researchers tested 47 children with ADHD between 5 and 16 years old to determine which variant of the dopamine transporter gene they carried. They focused on two specific variants -- called 9R and 10R -- of the transporter gene and evaluated how varying doses of methylphenidate would affect ADHD symptoms, impairment, and stimulant side effects.

The majority of the patients had one or two copies of the 10R variant. Of these children, nearly 60 percent had excellent response to the highest dosage (54 milligrams). In contrast, of the patients with two copies of the 9R variant, none displayed such dramatic improvement.

Results of the current study appear in the July issue of the journal Neuropsychopharmachology.

Source: Newswise
'"/>




Page: 1

Related medicine news :

1. Diet Can Influence Allergic Skin Reactions
2. Influence of diet on allergic Reactions
3. Red Color Causes The Allergic Reaction To Strawberries
4. New Insight Gained For Allergic Reactions
5. Emergency Treatment Found Wanting In Anaphylactic Reactions
6. Cancer Causing Proteins Trigger Abnormal Biochemical Reactions In Cells
7. New Medicare Plan - Mixed Reaction among Pharmacists.
8. Drug Reactions First Present Themselves In The Mouth
9. Eye Drug Macugen Shows Allergic Reactions
10. Gender Difference In Reaction To Cancer
11. Mouse Model Demonstrates Immune System Reaction In Chlamydia Infection

Post Your Comments:
(Date:12/1/2009)..., RESEARCH TRIANGLE PARK, N.C., Dec. 1 /PRNewswire...n 2001 and have expanded over the years serving th...facility which was originally set up in an area of...rvices, as part of the suite of services by Max Ne... as a valuable offering. ,, The pharmacy invent...
(Date:12/1/2009)...EHIGH VALLEY, Pa., Dec. 1 /PRNewswire-FirstCall/ -...mpleted the previously announced sale of the asset...ted under the Airthane® and Versathane® ...ary of global polyurethane chemicals producer COIM..., manufacturing facility in Paulsboro, N.J. Terms ...
(Date:12/1/2009)...WASHINGTON, Dec. 1 Indi...e more likely than those with traditional coverage...to be more engaged in wellness programs, and to be...matter in holding down costs, according to survey ... Benefit Research Institute (EBRI). ,, At the ...
(Date:12/1/2009)..., PHOENIX, Dec. 1 Abrazo Media Rel... Scoliosis ( http:// www.pedsorthopaedics.com ) lo...rthopaedic surgeon Dr. J. Hunt Udall to its practi... and orthopaedic surgery after recently completing...Boston, Massachusetts where he focused on adult an...
(Date:12/1/2009)... FORT LAUDERDALE, Fla., Dec. 1 Orb...enrollment in the randomized clinical trial of the...bo Stent). ,, A prospective, randomized, multic...n of an ablu M inal sirolimus coat ED bio- E... up to 20 sites in Asia, Australia, Europe and Sou...
Breaking Medicine News(10 mins):Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:Orthopaedic Surgeon Dr. J. Hunt Udall Joins the Center for Pediatric Orthopaedics and Scoliosis as One of Few Trained Doctors to Perform Minimally Invasive Hip Arthroscopy 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4
... was said that 44 % of women suffer from Intimate ...affects both the mental health as well as the phys...d by senior investigators of the Group Health Cent...erienced IPV during their adult lifetime. He ...
...st is to be conducted among children in the age gr...r the kids are following proper eating habits// an... health. This step is mainly to tackle the worseni...uld stigmatize some children. But the Government o...
...ingh asked the striking medicos to end strike and ...cable way and the students// should have faith in ...ion in the on-going protest against reservation fo...report to him. One of the plans is to increa...
...untants, lawyers joined the protesting medical stu...ace march started// at Maulana Azad Medical Colleg... surprisingly peaceful rally with no sloganeering....ing silently to let it be known that we feel stron...
...ined by other professionals including Bollywood st...the quota// increase for OBCs in higher educationa...torshri Hall in south Mumbai and march towards Aza...e held into the baton-charge on the medical studen...
...ere has claimed to have invented a device which ca...he muscles of his forehead.// The 'Galbenato...rd position in the engineering category at the rec... a point on the skin just above eyebrows as a data...
Other Medicine News:Health News:Prime Minister Asks Medicos to End Strike 2
(Date:12/1/2009)...-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYS...y completed preclinical study has affirmed the bio... Taxotere® (docetaxel). Shin Poong Pharmaceu...rea, independently conducted the study and data an...he bioequivalence and comparable overall safety of...
(Date:12/1/2009)...ewswire/ -- Sagent Pharmaceuticals, Inc., a privat...nnounced the launch of two antibiotics: cefoxitin ...USP. Both are antibiotics of the cephalosporin fam...am-negative bacteria. Sagent will launch ceftriaxo...ur vial sizes launched by Sagent in July 2008. Ce...
(Date:12/1/2009)...ewswire/ -- ,, Overweight Children May Develop... from The Children,s Hospital at Montefiore in New...may be causing damage to their spines. Researchers...ts between the ages of 12 and 20 who complained of...four-year period. The results showed an associatio...
Breaking Medicine Technology:ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 2ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514 3Sagent Pharmaceuticals Bolsters Antibiotics Offering With Two Product Launches 2Tuesday, Dec. 1: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 2Tuesday, Dec. 1: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 3Earliest animals lived in a lake environment research shows 9384 1Earliest animals lived in a lake environment research shows 9384 2Earliest animals lived in a lake environment research shows 9384 31 nano step closer to weighing a single atom 13222 11 nano step closer to weighing a single atom 13222 2Charging ahead 3A University of Houston team revealing secrets of electricity producing materials 13220 1Charging ahead 3A University of Houston team revealing secrets of electricity producing materials 13220 2Charging ahead 3A University of Houston team revealing secrets of electricity producing materials 13220 3
...profile and potential for lower cardiac toxicity d...t, SEATTLE, March 6 Cell Therapeutics, Inc.,(CTI...investigational drug,pixantrone will be studied in...ondation Charcot Stichting, in Brussels, Belgium, ... studying new therapies for the treatment,for mult...
... March 5 Transgenomic, Inc. (OTC,Bulletin Board: ...today,announced that it has entered into agreement...e Phase II trials representing more than $500,000 ...and our growing pharmaceutical partnerships and,pr...dation of our unique,mutation discovery and detect...
Other Medicine Technology:Pixantrone to be Studied in Phase I/II Trial for Aggressive Multiple Sclerosis 2Pixantrone to be Studied in Phase I/II Trial for Aggressive Multiple Sclerosis 3Pixantrone to be Studied in Phase I/II Trial for Aggressive Multiple Sclerosis 4Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies 2
Genesis II Patellar Instruments
NexGen Complete Knee Solution IM Instrumentation
MIS Tibial Saw Guide
MIS Distal Femoral Alignment/Saw Guide and Intramedullary Rod
Medicine Products: